The aim of the study was to assess, among people living with HIV, knowledge of their latest HIV viral load (VL) and CD4 count. Methods Agreement between self-report and clinic record was assessed among 2771 HIV-diagnosed individuals on antiretroviral treatment (ART) in the UK Antiretrovirals, Sexual Transmission ...

In early September, Poland became the platform for the first presentation and discussion of the "Concept of the East Europe and Central Asia Union of People Living with HIV on access to treatment in the EECA region". The key aspect of the Concept is the ...

On September 6, in Poland, the ECUO held a working meeting jointly with the international experts, representatives of governmental institutions and activists of PLHIV communities, to discuss the new concept of access to innovative treatment. You can review the concept here. Without exaggeration, it is a landmark meeting that took place on the edge of two Europes: East and West. In West Europe, the epidemic is brought under control already, so HIV-infected people have an opportunity ...

HIV-positive U.S. residents in the large NA-ACCORD cohort had an atherosclerotic myocardial infarction (MI) rate 20% higher than people in a U.S. general-population cohort, newly published data reveal. This 29,169-person analysis also linked MI risk to lower CD4 count, higher viral load and a host ...

The World Health Organization (WHO) and UNAIDS have released a joint statement on HIV testing services that reinforces two key principles that ensure a human rights-based and public health approach to HIV testing. The statement says that HIV testing, no matter how it is delivered, must always respect ...

When Canadian researchers asked HIV-positive people over the age of 50 how they would define “successful ageing”, six key themes emerged – accepting limitations, staying positive, maintaining social support, taking responsibility, living a healthy lifestyle, and engaging in meaningful activities. Writing in the International Journal of STD ...

In Chisinau, at the annual coordination meeting of the Participants of the General Meeting of the ECUO, the priorities for advocacy activities for the coming year were identified. The ECUO participants and focal points from 15 countries of the Eastern Europe and Central Asia, as well ...

Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions — infectious particles — to be connected to infectivity. The findings, published in Proceedings of the National Academy of Sciences, could help lead to the development of novel therapies for HIV ...

AIDES and PLUS announced to conference attendees from the world over results from the biggest European survey ever to be conducted regarding knowledge, interest and utilisation of PrEP, Flash! PrEP in Europe. This presentation revealed the principal barriers, both individual and structural, regarding access to this ...

PARIS — The last time the International AIDS Society Conference on HIV Science met in 2003, fewer than 2 million people globally were on HIV treatment. As the event returned to Paris this week, UNAIDS reported 19.5 million people are now taking antiretroviral therapy, or ART. The numbers put ...

In 2015, viral hepatitis caused the death of 1 million 340 thousand people around the world. Such data are published in the report of the World Health Organization, during the International Congress on diseases of the liver ILC 2017 held in Amsterdam. One of the causes of high mortality is the ...

Extension of 2013 agreement allows an additional 1.4 million people living with HIV to benefit from sublicensed generics of World Health Organization-recommended antiretroviral. Paris, 25 July 2017 — The Medicines Patent Pool (MPP) has signed an extension of its licensing agreement with biopharmaceutical company Bristol-Myers Squibb ...

AbbVie’s new pangenotypic regimen combining glecaprevir and pibrentasvir cured almost all HIV-positive people with hepatitis C co-infection in the EXPEDITION-2 study, according to a presentation on Monday at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris. Glecaprevir/pibrentasvir (Maviret) is expected to be approved ...

HVTN 705 vaccine study passes its “go” criteria: due to start this autumn A year ago, one of the biggest pieces of prevention news at the Durban International AIDS Conference was the announcement that a large HIV vaccine efficacy study would start in South Africa. HVTN 702, ...

WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories ...

A new report released today ahead of the 9th IAS Conference on HIV Science documents 2016 funding and highlights a continuing trend of flat or declining funding and its potential impact on further innovation in HIV prevention research and development (R&D). The Resource Tracking for HIV Prevention ...

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV. The first set of recommendations ...

Ahead of next week’s International AIDS Society Conference on HIV Science in Paris, France, the Global Fund to Fight AIDS, Tuberculosis and Malaria today announced new results that highlight accelerating progress in providing HIV prevention, treatment and care services. The results show that 11 million people are receiving ...